BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23027709)

  • 1. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.
    Dobrowolska H; Gill KZ; Serban G; Ivan E; Li Q; Qiao P; Suciu-Foca N; Savage D; Alobeid B; Bhagat G; Colovai AI
    Cytometry B Clin Cytom; 2013; 84(1):21-9. PubMed ID: 23027709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia.
    Porwit-MacDonald A; Ivory K; Wilkinson S; Wheatley K; Wong L; Janossy G
    Leukemia; 1995 Jul; 9(7):1191-8. PubMed ID: 7543174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
    Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
    Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].
    Shi H; Zhu F; Xiao AQ; Zhang ZR; Zhang R
    Ai Zheng; 2006 Jun; 25(6):762-4. PubMed ID: 16764777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
    Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
    Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.
    Larsen HØ; Roug AS; Just T; Brown GD; Hokland P
    Cytometry B Clin Cytom; 2012 Jan; 82(1):3-8. PubMed ID: 22173921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
    Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
    Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
    Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
    Reuss-Borst MA; Bühring HJ; Schmidt H; Müller CA
    Leukemia; 1994 Feb; 8(2):258-63. PubMed ID: 7508533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.
    Drexler HG; Thiel E; Ludwig WD
    Leukemia; 1993 Apr; 7(4):489-98. PubMed ID: 7681917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.